L
Letoon Holding
Ultrasonic reclamation of vegetable waste into high-value ingredients
About Letoon Holding
Letoon Holding Ltd is a London-based biotechnology company founded in 2023 by Matteo Turi and Giuseppe Perla. The company operates on a circular economy model, specializing in transforming vegetable waste and plant matter into high-value active ingredients for the pharmaceutical, cosmetic, and food industries. It employs innovative ultrasonic reclamation technologies to extract these ingredients, such as recovering lycopene from tomato waste, ensuring high yields and purity without the use of chemical solvents. This eco-friendly and energy-efficient process allows the company to contribute to reducing the global food waste problem while producing valuable commodities.
The company was incorporated in June 2023 and has since secured significant funding to scale its operations. In November 2023, Letoon Holding obtained a £20 million ($24.6M) capital commitment from Nimbus Capital, a private investment group, structured as a Growth Equity Agreement contingent on a future public listing on the London Stock Exchange. This funding is intended to establish the company as a global leader in its niche. Letoon Holding's business model involves supplying high-value commodities to B2B customers in the pharmaceutical, cosmetic, and food sectors, with plans to commence major operations in the first half of 2025 and pursue industry-related mergers and acquisitions.
The leadership team brings extensive experience to the venture. CEO and co-founder Matteo Turi has a 28-year background in M&A, clean technologies, and life sciences. The company's scientific endeavors are bolstered by partnerships with eight universities and the Italian Society of Natural Medicine (SIMN), focusing on research into anti-cancer and anti-viral products. The co-founding team also includes Treelife Pharma, Antonello Sannia, and Claudio Spada, combining deep experience in pharmaceuticals, biotechnology, and phytotherapy.
Source: Dealroom company dataAt a glance
- Founded
- 2023
- Headquarters
- London, United Kingdom
- Sector
- Biotech & Life Sciences
News
Open roles
Letoon Holding in the London ecosystem
The Letoon Holding office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Nimbus Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Letoon Holding on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Letoon Holding on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

